Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Biomarkers in prostate cancer surveillance and screening: past, present, and future.

Cary KC, Cooperberg MR.

Ther Adv Urol. 2013 Dec;5(6):318-29. doi: 10.1177/1756287213495915. Review.

PMID:
24294290
[PubMed]
Free PMC Article
2.

Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?

Lee DH, Jung HB, Park JW, Kim KH, Kim J, Lee SH, Chung BH.

Yonsei Med J. 2013 May 1;54(3):665-71. doi: 10.3349/ymj.2013.54.3.665.

PMID:
23549812
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ.

World J Urol. 2012 Apr;30(2):181-7. doi: 10.1007/s00345-011-0818-5. Epub 2011 Dec 31.

PMID:
22210512
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Roobol MJ, Schröder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW.

World J Urol. 2012 Apr;30(2):149-55. doi: 10.1007/s00345-011-0804-y. Epub 2011 Dec 28.

PMID:
22203238
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.

Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A; Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer (appendix).

BJU Int. 2012 Jun;109(11):1636-47. doi: 10.1111/j.1464-410X.2011.10633.x. Epub 2011 Nov 11.

PMID:
22077593
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.

Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein E, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Schröder FH, Lilja H.

Clin Cancer Res. 2010 Sep 1;16(17):4374-81. doi: 10.1158/1078-0432.CCR-10-1328. Epub 2010 Aug 24. Erratum in: Clin Cancer Res. 2011 Jun 1;17(11):3852.

PMID:
20736330
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prostate cancer: utility of the risk indicator model in screening.

Loeb S, Catalona WJ.

Nat Rev Urol. 2010 Apr;7(4):184-5. doi: 10.1038/nrurol.2010.41. No abstract available.

PMID:
20383184
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prediction models in urology: are they any good, and how would we know anyway?

Vickers A.

Eur Urol. 2010 Apr;57(4):571-3; discussion 574. doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29. No abstract available.

PMID:
20071072
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk